CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats, clustered, Short palindromic repeats at regular intervals) It's a gene-editing technique. recently, European Patent Office (EPO) Most of the objection proceedings involve patent applications for such technologies. 3 month 17 day, EPO Dissident agencies overthrew American biotech companies Sigma-Aldrich Control of ownership EP3138910B1 Patent no, The reason is that the patent lacks creativity. The patent is contested Sigma-Aldrich the 6 a CRISPR One patent.
Most previous programs focused only on priorities. right Sigma-Aldrich In terms of, The patent was revoked as its principal CRISPR Barriers to technology being used in the human cellular environment and obtaining patents.
CRISPR It's a special kind of DNA chain. Cas9 It's a way to cut through these DNA Chain protein.
Reprinted from China Intellectual Property Network
disclaimer: This website reprint articles are from the Internet, Does not represent the views of this website or confirm the authenticity of its content. If the source is mislabeled or the copyright of the article is involved, Please contact this website, This website will be corrected in due course, delete, thank you.
Patent infringement rights protection
